Table 1. Clinical characteristics of the subjects enrolled in the study.
| Group | HC | CHB | HBV-LC |
|---|---|---|---|
| Subjects | 20 | 30 | 40 |
| Male | 12 | 18 | 30 |
| Female | 8 | 12 | 10 |
| Age(years) | 35.5(24–45) | 34(18–71) | 48.5(27–71) |
| ALT(U/L) | 23.5(10–39) | 286(55–889) | 27.5(11–124) |
| AST(U/L) | 24.5(12–36) | 166(25–1138) | 38.5(14–250) |
| TBIL(μmol/L) | 8.45(3.8–16.3) | 28.95(6.0–400.1) | 22.65(6.7–468.8) |
| Child-Pugh(A/B/C) | ND | ND | 14/15/7 |
| HBeAg positive | 0 | 20 | 18 |
| HBV-DNA(copies/ml) | |||
| 1 × 103−1 × 105 copies/ml | 0 | 8 | 31 |
| >1 × 105 copies/ml | 0 | 12 | 9 |
Data are shown as median and range. HC, healthy control; CHB, chronic hepatitis B patients; HBV-LC, HBV associated liver cirrhosis patients. ND, not determined.